2.37
price down icon4.05%   -0.10
pre-market  Vorhandelsmarkt:  2.38   0.010   +0.42%
loading
Schlusskurs vom Vortag:
$2.47
Offen:
$2.45
24-Stunden-Volumen:
2.38M
Relative Volume:
1.47
Marktkapitalisierung:
$260.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-134.24M
KGV:
-1.339
EPS:
-1.77
Netto-Cashflow:
$-121.34M
1W Leistung:
-5.20%
1M Leistung:
-0.42%
6M Leistung:
-42.89%
1J Leistung:
-59.31%
1-Tages-Spanne:
Value
$2.325
$2.47
1-Wochen-Bereich:
Value
$2.2104
$2.535
52-Wochen-Spanne:
Value
$1.285
$7.85

Annexon Inc Stock (ANNX) Company Profile

Name
Firmenname
Annexon Inc
Name
Telefon
(650)-822-5500
Name
Adresse
1400 SIERRA POINT PARKWAY, BRISBANE
Name
Mitarbeiter
100
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
ANNX's Discussions on Twitter

Vergleichen Sie ANNX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ANNX
Annexon Inc
2.37 274.29M 0 -134.24M -121.34M -1.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Annexon Inc Stock (ANNX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-03-01 Hochstufung JP Morgan Neutral → Overweight
2023-12-21 Hochstufung BofA Securities Neutral → Buy
2023-10-30 Eingeleitet Wells Fargo Overweight
2023-05-26 Herabstufung BofA Securities Buy → Neutral
2023-05-25 Herabstufung JP Morgan Overweight → Neutral
2022-09-16 Eingeleitet Jefferies Buy
2022-09-09 Eingeleitet BTIG Research Buy
2021-11-30 Eingeleitet H.C. Wainwright Buy
2021-09-23 Eingeleitet Cantor Fitzgerald Overweight
2021-01-26 Eingeleitet Needham Buy
2020-08-18 Eingeleitet BofA Securities Buy
2020-08-18 Eingeleitet Cowen Outperform
2020-08-18 Eingeleitet JP Morgan Overweight
Alle ansehen

Annexon Inc Aktie (ANNX) Neueste Nachrichten

pulisher
Jul 22, 2025

Annexon Inc. Stock Analysis and ForecastFree Stock Selection - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Annexon Inc. stockFast-track wealth growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Annexon Inc. stock priceRapidly expanding wealth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Annexon Inc. a good long term investmentHigh-performance investment picks - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Why Annexon Inc. stock attracts strong analyst attentionCapital Doubling Tips - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans? - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Is Annexon Inc. stock a growth or value playHigh Reward Risk Balanced Trading - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Annexon Inc (ANNX) Stock: A Comprehensive 52-Week Review - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

Annexon EVP Yednock sells $2.9k in shares By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Annexon EVP Yednock sells $2.9k in shares - Investing.com Australia

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Annexon Inc. stock price move sharplyTop Performing Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Annexon Inc. stock performs during market volatilityWeekly Big Movers - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Annexon: Lead GBS Therapy Stokes Near Term Potential (NASDAQ:ANNX) - Seeking Alpha

Jul 14, 2025
pulisher
Jul 11, 2025

Annexon Target of Unusually Large Options Trading (NASDAQ:ANNX) - Defense World

Jul 11, 2025
pulisher
Jul 09, 2025

Annexon (NASDAQ:ANNX) Stock Price Down 0.7% – Should You Sell? - Defense World

Jul 09, 2025
pulisher
Jun 18, 2025

Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025 - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrop - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

Bank of America Corp DE Sells 137,220 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 17, 2025
pulisher
Jun 17, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Sold by Park Avenue Securities LLC - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Market Highlights: Annexon Inc (ANNX) Ends on a Low Note at 2.49 - DWinneX

Jun 16, 2025
pulisher
Jun 13, 2025

49,062 Shares in Annexon, Inc. (NASDAQ:ANNX) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Bought by California State Teachers Retirement System - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Estimates Annexon FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

Annexon Biosciences Holds Annual Stockholders Meeting - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Reduces Stock Holdings in Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Sells 49,438 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Grows Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 07, 2025

Finanzdaten der Annexon Inc-Aktie (ANNX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):